Trabajo presentado por la Dra. Montserrat García González en el Congreso anual de la Acedemia Americana de Oftalmología: Femtosecond-Assisted LASIK With and Without Mitomycin C Performed to Correct Hyperopia: A 15-Month Follow-up
To compare the 15-month visual and refractive results of FemtoLASIK with and without mitomycin C (MMC) to correct hyperopia.
152 consecutive eyes were divided in two groups: applying 0.02% MMC for five seconds and without MMC. We compared the refractive results 15 months postoperatively.
No significant differences were found in the postoperative uncorrected distance visual acuity, corrected distance visual acuity and residual refraction. Retreatment rate was significantly lower in the MMC-group (6.58% versus 10.53%) (P=0.01). CONCLUSION: Hyperopic FemtoLASIK provides good refractive outcomes in a 15-month follow-up. The use of MMC seems to reduce the incidence of retreatments.